Quell wearable pain relief approved

FTC Refunds Almost $3.9 Million to Purchasers of Deceptively Advertised Quell Wearable Pain-Relief Device, Federal Trade Commission September 8, 2020

NeuroMetrix begins shipping Quell device, May 29, 2015

NeuroMetrix reported Thursday that it has initiated its first Quell wearable pain relief device shipments to U.S. healthcare providers. The product was FDA 510(k)-cleared for chronic pain treatment without a prescription in 2014.

Jason Scott, FDAnews June 1, 2015

Quell features non-invasive neurostimulation technology to alleviate pain in patients with diabetic nerve pain, low back and leg pain, fibromyalgia and osteoarthritic pain, among others. The device is lightweight and meant to be worn during the day and the night.

Quell users can use a smart phone app to track and customize their therapy, the Waltham, Mass., company says.

The device maker will seek CE Mark approval for the product this year, a spokesman told Device Daily Friday.

NeuroMetrix designs wearable medical technology and point-of-care tests for chronic pain, nerve disease and sleep disorder management.

Source FDAnews

NeuroMetrix Quell Neurostimulator at CES 2015. Medgadget. Youtube Jan 20, 2015

Also see
Wearable Nerve Stimulator Improves Chronic Pain in Medscape
Can tech replace painkillers? in Engadget
Hands-On With Quell Wearable Pain Relief Device in Medgadget
NeuroMetrix and GlaxoSmithKline Consumer Healthcare Announce Strategic Collaboration to Develop and Expand Access to Quell Wearable Pain Relief Technology in Nasdaq